Group One Trading’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.48K Buy
+2,448
New +$3.48K ﹤0.01% 1736
2025
Q1
Hold
0
1944
2024
Q4
Hold
0
2017
2024
Q3
Sell
-5,549
Closed -$6.1K 1697
2024
Q2
$6.1K Sell
5,549
-128,282
-96% -$141K ﹤0.01% 1388
2024
Q1
$166K Buy
133,831
+56,630
+73% +$70.2K ﹤0.01% 701
2023
Q4
$81.1K Buy
77,201
+8,911
+13% +$9.36K ﹤0.01% 960
2023
Q3
$468K Buy
68,290
+18,259
+36% +$125K ﹤0.01% 537
2023
Q2
$519K Sell
50,031
-41,395
-45% -$429K ﹤0.01% 476
2023
Q1
$740K Buy
+91,426
New +$740K ﹤0.01% 377
2022
Q4
Sell
-457
Closed -$7K 1892
2022
Q3
$7K Sell
457
-1,999
-81% -$30.6K ﹤0.01% 1641
2022
Q2
$34K Sell
2,456
-256
-9% -$3.54K ﹤0.01% 1377
2022
Q1
$47K Sell
2,712
-707
-21% -$12.3K ﹤0.01% 1449
2021
Q4
$50K Sell
3,419
-2,623
-43% -$38.4K ﹤0.01% 1573
2021
Q3
$109K Buy
6,042
+4,273
+242% +$77.1K ﹤0.01% 1321
2021
Q2
$31K Sell
1,769
-14,380
-89% -$252K ﹤0.01% 1619
2021
Q1
$407K Sell
16,149
-31,484
-66% -$793K ﹤0.01% 833
2020
Q4
$308K Buy
47,633
+40,033
+527% +$259K ﹤0.01% 756
2020
Q3
$20K Buy
7,600
+5,100
+204% +$13.4K ﹤0.01% 1222
2020
Q2
$4K Buy
+2,500
New +$4K ﹤0.01% 1247
2020
Q1
Sell
-11,451
Closed -$22K 1337
2019
Q4
$22K Buy
11,451
+8,954
+359% +$17.2K ﹤0.01% 1023
2019
Q3
$3K Sell
2,497
-16,085
-87% -$19.3K ﹤0.01% 1186
2019
Q2
$41K Buy
18,582
+17,732
+2,086% +$39.1K ﹤0.01% 852
2019
Q1
$5K Buy
+850
New +$5K ﹤0.01% 1048
2018
Q4
Hold
0
1341
2017
Q3
Hold
0
1277
2017
Q2
Hold
0
1285